Deutsche Bank analyst Pito Chickering raised the firm’s price target on BrightSpring Health (BTSG) to $30 from $25 and keeps a Buy rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BTSG:
- BrightSpring Health Services: Strong Market Position and Growth Potential Justify Buy Rating
- BrightSpring Health price target raised to $41 from $37 at TD Cowen
- BrightSpring Health Services: Strong Pharmacy Solutions Performance and Strategic Moves Justify Buy Rating
- BrightSpring Health Services Reports Strong Q2 2025 Results
- BrightSpring Health Services Reports Strong Earnings Growth